Latest News
- 15 Oct 2021 – Invitation to the Presentation of Alligator Bioscience´s Interim Report January - September 2021 on October 21, 2021
- 7 Oct 2021 – Notice of extraordinary general meeting in Alligator Bioscience AB
- 7 Oct 2021 – Alligator carries out a 100 percent secured rights issue of approximately SEK 257 million
- 30 Sep 2021 – Alligator Bioscience Announces First Patient Dosed in OPTIMIZE-1 Phase II Clinical Trial Evaluating Mitazalimab in Combination with mFOLFIRINOX for the Treatment of Pancreatic Cancer
